VMP 8427211000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Co-careldopa 12.5mg/50mg/5ml oral suspension
BNF code 0409010N0AAAVAV
Virtual Therapeutic Moiety Co-careldopa
Basis of preferred name BAN - British Approved Name
Date of name applicability 18 Nov 2004
Previous name Co-careldopa 12.5mg/50mg oral suspension
Basis of previous name BAN - British Approved Name
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Continuous
Virtual Product Ingredient
Ingredient Carbidopa monohydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 73579000
Strength value numerator 2.500
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Virtual Product Ingredient
Ingredient Levodopa
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 10.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route suspension.oral
Dose Form
Formulation Oral suspension
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Co-careldopa 12.5mg/50mg/5ml oral suspension (Drug Tariff Special Order)
Virtual Medicinal Product Packs
Co-careldopa 12.5mg/50mg/5ml oral suspension 100 ml
Co-careldopa 12.5mg/50mg/5ml oral suspension 1 ml

dm+d data retrieved from TRUD: release NHSBSA_10.3.0_20241028000001, imported on 29th October 2024 at 03:59:29.

Feedback